Acceptys, Inc.

BUBBLE MOUSE

MOUSE;Live laboratory animals, namely, an immunodeficient mouse, capable of having human immune system introduced into said mouse, among other systems/items;

C.H.A.B.

BIOCHEMICALS AND BIOLOGICAL MATERIALS, NAMELY, HUMAN MONOCLONAL ANTIBODIES FOR IN VIVO (ANIMAL) AND IN VITRO SCIENTIFIC OR RESEARCH USE;

COMPLETELY HUMAN ANTIBODY

Completely Human Antibody (Antibodies);

I.M.A.G.E.

IMAGE;IMAGE DESCRIBES TECHNOLOGY THAT INVOLVES THE ENGRAFTMENT HUMAN IMMUNE CELLS INTO AN IMMUNODEFICIENT ANIMAL, PREFERABLY A MOUSE, IN ORDER TO GENERATE ANTIBODIES AGAINST ANY GIVEN ANTIGEN THAT IS INTRODUCED INTO SUCH ANIMAL/MOUSE HENCE, WE HAVE APPLIED FOR THE TRADEMARK IMAGE, WHICH STANDS FOR IN MOUSE ANTIBODY GENERATING ENVIRONMENT;

IMMUNOCREATION

IMMUNE CREATION;Technology that utilizes animal model of human immune system, including but not limited to creation of human antibodies in said animal model;

IMMUNOPROSPECTING

Method of locating/securing antibody producing lymphocytes, and use thereof, (or any other cell type of interest);

IMMUNOTARGETING

IMMUNOGENIC TARGETING;Process by which antibodies are utilized to identify, or target immunogenic materials that may then be used to develop therapies;

MFP2

MODIFIED FUSION PARTNER;Modified Fusion Partner of 2nd Generation, which represents an immortal cell line that can be used to create hybridomas, capable of production a variety of materials, including human proteins, such as antibodies, when fused with antibody producing cells;